Literature DB >> 30310441

Clinical Diagnosis and Management of Resistant Hypertension.

Costas P Tsioufis1, Alexandros Kasiakogias1, Dimitrios Tousoulis1.   

Abstract

Resistant hypertension (RHT) is variably defined as insufficient blood pressure (BP) response to multiple drug treatment. Prevalence of RHT has been thoroughly studied in the recent years, ranging from about 5 to 30 % in various cohorts. Initial management of patients with apparent RHT requires identification of true treatment resistance by out-of-office BP measurements, assessment of adherence and screening for treatable causes of uncontrolled BP. Endorsement of lifestyle modifications and maximisation of the doses of a suitable regimen, preferably with the further addition of an aldosterone antagonist, are the mainstay of treatment. An invasive approach to RHT, mainly represented by renal nerve ablation, should be kept for persistently severe cases managed in a specialised hypertension centre.

Entities:  

Keywords:  Resistant hypertension; clinical management; diagnosis; hypertension; uncontrolled blood pressure

Year:  2016        PMID: 30310441      PMCID: PMC6159472          DOI: 10.15420/ecr.2016:1:2

Source DB:  PubMed          Journal:  Eur Cardiol        ISSN: 1758-3756


  60 in total

1.  Increased sodium intake correlates with greater use of antihypertensive agents by subjects with chronic kidney disease.

Authors:  Neil Boudville; Sharon Ward; Mark Benaroia; Andrew A House
Journal:  Am J Hypertens       Date:  2005-10       Impact factor: 2.689

2.  Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design.

Authors:  Felix Mahfoud; Michael Böhm; Michel Azizi; Atul Pathak; Isabelle Durand Zaleski; Sebastian Ewen; Kostantinos Tsioufis; Bert Andersson; Peter J Blankestijn; Michel Burnier; Gilles Chatellier; Sameer Gafoor; Guido Grassi; Michael Joner; Sverre E Kjeldsen; Thomas Felix Lüscher; Melvin D Lobo; Chaim Lotan; Gianfranco Parati; Josep Redon; Luis Ruilope; Isabella Sudano; Christian Ukena; Evert van Leeuwen; Massimo Volpe; Stephan Windecker; Adam Witkowski; William Wijns; Thomas Zeller; Roland E Schmieder
Journal:  Eur Heart J       Date:  2015-05-18       Impact factor: 29.983

Review 3.  Renal nerve ablation for resistant hypertension: how did we get here, present status, and future directions.

Authors:  Vasilios Papademetriou; Amir Adel Rashidi; Costas Tsioufis; Michael Doumas
Journal:  Circulation       Date:  2014-04-01       Impact factor: 29.690

4.  Evening versus morning dosing of antihypertensive drugs in hypertensive patients with sleep apnoea: a cross-over study.

Authors:  Alexandros Kasiakogias; Costas Tsioufis; Costas Thomopoulos; Ioannis Andrikou; Dimitrios Aragiannis; Kyriakos Dimitriadis; Dimitrios Tsiachris; Grzegorz Bilo; Skevos Sideris; Konstantinos Filis; Gianfranco Parati; Christodoulos Stefanadis
Journal:  J Hypertens       Date:  2015-02       Impact factor: 4.844

Review 5.  Role of neprilysin inhibitor combinations in hypertension: insights from hypertension and heart failure trials.

Authors:  Chirag Bavishi; Franz H Messerli; Bernard Kadosh; Luis M Ruilope; Kazuomi Kario
Journal:  Eur Heart J       Date:  2015-04-21       Impact factor: 29.983

6.  Effects of continuous positive airway pressure on blood pressure in hypertensive patients with obstructive sleep apnea: a 3-year follow-up.

Authors:  Alexandros Kasiakogias; Costas Tsioufis; Costas Thomopoulos; Dimitrios Aragiannis; Manos Alchanatis; Dimitrios Tousoulis; Vasilios Papademetriou; John S Floras; Christodoulos Stefanadis
Journal:  J Hypertens       Date:  2013-02       Impact factor: 4.844

7.  Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension.

Authors:  Rodrigo P Pedrosa; Luciano F Drager; Carolina C Gonzaga; Marcio G Sousa; Lílian K G de Paula; Aline C S Amaro; Celso Amodeo; Luiz A Bortolotto; Eduardo M Krieger; T Douglas Bradley; Geraldo Lorenzi-Filho
Journal:  Hypertension       Date:  2011-10-03       Impact factor: 10.190

8.  Increased dietary sodium is related to severity of obstructive sleep apnea in patients with resistant hypertension and hyperaldosteronism.

Authors:  Eduardo Pimenta; Michael Stowasser; Richard D Gordon; Susan M Harding; Michel Batlouni; Bin Zhang; Suzanne Oparil; David A Calhoun
Journal:  Chest       Date:  2013-04       Impact factor: 9.410

Review 9.  Effect of longer-term modest salt reduction on blood pressure.

Authors:  Feng J He; Jiafu Li; Graham A Macgregor
Journal:  Cochrane Database Syst Rev       Date:  2013-04-30

10.  Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial.

Authors:  Bryan Williams; Thomas M MacDonald; Steve Morant; David J Webb; Peter Sever; Gordon McInnes; Ian Ford; J Kennedy Cruickshank; Mark J Caulfield; Jackie Salsbury; Isla Mackenzie; Sandosh Padmanabhan; Morris J Brown
Journal:  Lancet       Date:  2015-09-20       Impact factor: 79.321

View more
  2 in total

1.  Hypertensive patients' knowledge and practices on lifestyle modification in Extension 6, Middelburg.

Authors:  Amir Rahimi; Lushiku Nkombua
Journal:  S Afr Fam Pract (2004)       Date:  2022-08-24

2.  Consensus paper on the evaluation and treatment of resistant hypertension by the Turkish Society of Cardiology.

Authors:  Asife Sahinarslan; Emine Gazi; Meryem Aktoz; Cigdem Ozkan; Gülay Ulusal Okyay; Ozgul Ucar Elalmis; Erdal Belen; Reviewers Atila Bitigen; Ulver Derici; Neslihan Bascil Tutuncu; Aylin Yildirir
Journal:  Anatol J Cardiol       Date:  2020-09       Impact factor: 1.596

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.